Clinical Trials Browser

Phase 3 × INDUSTRY × perifosine × Clear all

NCT01002248 2018-02-09

Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma Patients

Phase 3 Terminated

Multiple Myeloma

NCT01097018 2013-07-02

X-PECT

Phase 3 Completed

Gastrointestinal

Colorectal Neoplasms